Oncolytics Biotech Inc. (ONCY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 114.96M |
| Enterprise Value | 108.59M |
| P/E Ratio | -4.04 |
| PEG Ratio | -0.49 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -29.79 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.65 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -4.35 |
| Return On Equity | 52.14 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -70,000 |
| EBITDA | -39.41M |
| Net Income | -39.46M |
| Diluted EPS | -0.41 |
Balance Sheet
| Total Cash | 5.49M |
| Total Cash/Share | 0.05 |
| Total Debt | 508,000 |
| Total Debt/Equity | -0.1 |
| Current Ratio | 1.38 |
| Book Value Per Share | -0.05 |
Price History
| 52-Week Change | 50.71 |
| 52-Week High | 1.51 |
| 52-Week Low | 0.56 |
| Moving Average 50 Days | 0.93 |
| Moving Average 200 Days | 1.03 |
Statistics
| Average Volume | 1.3M |
| Shares Outstanding | 100.36M |
| % Held by Institutions | 3.13 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:19 |
| Last Split Date | May 25, 2018 |
AD
